When did Amylyx Pharmaceuticals, Inc. report Q4 2024 earnings?

Amylyx Pharmaceuticals, Inc. (AMLX) reported Q4 2024 earnings on March 4, 2025 before market open.

What were Amylyx Pharmaceuticals, Inc.'s Q4 2024 revenue and EPS?

Amylyx Pharmaceuticals, Inc. reported revenue of $665.0K and eps of $-0.55 for Q4 2024.

Did Amylyx Pharmaceuticals, Inc. beat estimates in Q4 2024?

EPS missed the consensus estimate of $-0.49 by $0.06.

Where can I find Amylyx Pharmaceuticals, Inc.'s Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-031309) directly on SEC EDGAR. The filing index links above go to sec.gov.

Amylyx Pharmaceuticals, Inc. AMLX Q4 2024 Annual earnings

Reported March 4, 2025 · Before market open

Revenue$665.0K

EPS-$0.55Miss by $0.06

EPS estimate-$0.49

Next report

Aug 6, 2026 (In 1 week)

EPS estimate-$0.36

Financials

Q4 2024

Income statement

See full

Revenue--100%

Gross profit--100%

Operating income-$40.7M-2,202%

Net income-$37.5M-894%

EPS (diluted)-$0.54-871%

Balance sheet

See full

Cash & equivalents$77.4M-54.5%

Total debt$2.0M-53.2%

Total equity$164.8M-62.0%

Total assets$193.6M-62.6%

Cash flow

See full

Operating cash flow-$59.0M-535%

CapEx$20.0K-94.4%

Free cash flow-$59.0M-547%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$259.11M-73.9%

Enterprise value$183.7M-77.8%

P/S2.9×+0.3×

Profitability

See full

Gross margin93.2%-0.1pp

Operating margin-357.5%-368pp

Net margin-342.7%-356pp

FCF margin-190.6%-193pp

Returns & leverage

See full

Return on equity-100.9%-114pp

Debt / equity0×0.0×

Current ratio6.7×+1.0×

Versus estimates

Revenue

Q4 2024$665.0K

Diluted EPS

Q1 2026-$0.37Miss by $0.03 Q4 2025-$0.30Beat by $0.01 Q3 2025-$0.37Beat by $0.06 Q2 2025-$0.46Miss by $0.02 Q1 2025-$0.42Beat by $0.03

Q4 2024-$0.55Miss by $0.06

Ask the moment Amylyx Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Amylyx Pharmaceuticals, Inc. report Q4 2024 earnings?: Amylyx Pharmaceuticals, Inc. (AMLX) reported Q4 2024 earnings on March 4, 2025 before market open.
What were Amylyx Pharmaceuticals, Inc.'s Q4 2024 revenue and EPS?: Amylyx Pharmaceuticals, Inc. reported revenue of $665.0K and eps of $-0.55 for Q4 2024.
Did Amylyx Pharmaceuticals, Inc. beat estimates in Q4 2024?: EPS missed the consensus estimate of $-0.49 by $0.06.
Where can I find Amylyx Pharmaceuticals, Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-031309) directly on SEC EDGAR. The filing index links above go to sec.gov.